Table: begin end state 1 34 cytoplasmic 35 59 transmembrane 60 85 non-cytoplasmic 86 105 transmembrane 106 116 cytoplasmic 117 138 transmembrane 139 143 non-cytoplasmic 144 166 transmembrane 167 177 cytoplasmic 178 201 transmembrane 202 220 non-cytoplasmic 221 241 transmembrane 242 271 cytoplasmic 272 298 transmembrane 299 309 non-cytoplasmic 310 329 transmembrane 330 335 cytoplasmic 336 358 transmembrane 359 364 non-cytoplasmic
Input: >HSERO_RS21915 MSLASLEIAKAGRAQADATQVDPVRAYRRSMRRRLLFTVALLVLIIGAVVLDIATGPAGI AVQDLLATLLHADAAPAGLRVVVWEFRLPTAVMALLVGMCLGLGGGEMQTVLDNPLASPY TLGISAAAAFGAALAITFNWRFPALPAGMTVSACACAAALASVLVLERVARWRGGSTLGV ILFGIALVYSFQALIMLLQFVASEEALQGIVFWTMGSLARASWTTVAILGLAFALVAPFS LRDAWKLTALRLGEERAASFGIDMPRLRMLSLLRISVLAALSVSFVGTIGFVGLVAPHIA RLLLGEDHRYYLPGSAMAGGLIISLASVASKTLLPGVLIPVGIVTSLVGIPLFLIIVLRR LRRE
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server